A major challenge upon the completion of the Human Genome Project is to understand the roles that proteins play in normal and pathological processes. Large-scale proteomics efforts such as protein profiling, protein structure-determination, protein functional assignment, and protein-protein interaction analysis, are required to assign functions to the hundreds of thousands of human proteins. ProMab is a biotechnology company formed to meet these post-genomics needs. Founded and managed by a team of scientists with extensive experience in both academic and industrial biotechnology, ProMab develops and commercializes recombinant proteins and custom monoclonal antibodies through the integration of bioinformatics, gene cloning, protein expression and purification, and immunology, using novel high-throughput technologies. ProMab applies its proprietary proteins and antibodies to deliver innovative diagnostic products as well as services targeting the global biomedical market through collaborations with other biotechnology and bio-reagent companies. ProMab aims to be one of the leading suppliers of bio-reagents in the twenty-first century and is committed to improving human health.
|price on login20001|
|price on login20002|
Mouse Monoclonal Antibody to BCL-10
|price on login20003|
|price on login20004|
|price on login20005|
|price on login20006|
Mouse Monoclonal Antibody to CD4
|price on login20007|
Mouse Monoclonal Antibody to CD8
|price on login20008|
|price on login20009|
Mouse Monoclonal Antibody to IL-1a
|price on login20010|
..or do you want to contact us for more information?